|
|
 |
ADVIL ALLERGY SINUS Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
EDETATE DISODIUM Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DIBASIC CALCIUM PHOSPHATE DIHYDRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AEMCOLO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMVUTTRA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DIBUTYL SEBACATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DIETHYLENE GLYCOL MONOETHYL ETHER Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
EGG PHOSPHOLIPIDS Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DIETHYL PHTHALATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
DIMETHICONE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANORO ELLIPTA Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
APLENZIN Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AKYNZEO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|